{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:35:21Z","timestamp":1778582121262,"version":"3.51.4"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T00:00:00Z","timestamp":1392163200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0088562","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T22:05:00Z","timestamp":1392242700000},"page":"e88562","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hippocampal Neurochemical Changes in Senescent Mice Induced with Chronic Injection of D-Galactose and NaNO2: An In Vitro High-Resolution NMR Spectroscopy Study at 9.4T"],"prefix":"10.1371","volume":"9","author":[{"given":"Yan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianli","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezeng","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"CP Ferri","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jocn.2004.03.011","article-title":"Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer&apos;s disease","volume":"12","author":"VL Villemagne","year":"2005","journal-title":"J Clin Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer&apos;s disease","volume":"368","author":"K Blennow","year":"2006","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pbb.2011.02.002","article-title":"Alzheimer&apos;s disease and age-related memory decline (preclinical)","volume":"99","author":"AV Terry","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"CR Jack Jr","year":"1999","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/1533317507308779","article-title":"Distinct MRI atrophy patterns in autopsy-proven Alzheimer&apos;s disease and frontotemporal lobar degeneration","volume":"22","author":"GD Rabinovici","year":"2007","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer&apos;s disease with Pittsburgh Compound-B","volume":"55","author":"WE Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"CC Rowe","year":"2007","journal-title":"Neurology"},{"key":"ref9","first-page":"748","article-title":"Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer&apos;s disease","volume":"47","author":"AB Newberg","year":"2006","journal-title":"J Nucl Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.neurobiolaging.2006.06.018","article-title":"Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer&apos;s disease","volume":"28","author":"K Kantarci","year":"2007","journal-title":"Neurobiol Aging"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/brain\/awf226","article-title":"Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer&apos;s disease","volume":"125","author":"RM Dixon","year":"2002","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(00)02246-7","article-title":"Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer&apos;s disease","volume":"355","author":"E Adalsteinsson","year":"2000","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neurobiolaging.2009.05.002","article-title":"Reduced hippocampal glutamate in Alzheimer disease","volume":"32","author":"R Rupsingh","year":"2011","journal-title":"Neurobiol Aging"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/01.WNL.0000141849.21256.AC","article-title":"1H MR spectroscopy in common dementias","volume":"63","author":"K Kantarci","year":"2004","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neurobiolaging.2005.05.002","article-title":"Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy","volume":"27","author":"A Metastasio","year":"2006","journal-title":"Neurobiol Aging"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03166960","article-title":"Methodology of H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields","volume":"29","author":"I Tkac","year":"2005","journal-title":"Appl Magn Reson"},{"key":"ref17","first-page":"1484","article-title":"Investigating the metabolic changes due to visual stimulation using functional proton magnetic resonance spectroscopy at 7 T. J Cereb Blood Flow Metab","volume":"32","author":"Y Lin","year":"2012"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4329\/wjr.v3.i4.105","article-title":"Applications of multi-nuclear magnetic resonance spectroscopy at 7T","volume":"3","author":"MC Stephenson","year":"2011","journal-title":"World J Radiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.57.4.626","article-title":"Brain metabolite concentration and dementia severity in Alzheimer&apos;s disease: a (1)H MRS study","volume":"57","author":"W Huang","year":"2001","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0925-4927(03)00071-4","article-title":"Brain metabolism in Alzheimer disease and vascular dementia assessed by in vivo proton magnetic resonance spectroscopy","volume":"123","author":"S Herminghaus","year":"2003","journal-title":"Psychiatry Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/WNL.56.5.592","article-title":"Magnetic resonance spectroscopy in AD","volume":"56","author":"MJ Valenzuela","year":"2001","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1259\/bjr\/60346217","article-title":"1H magnetic resonance spectroscopy in dementia","volume":"2","author":"K Kantarci","year":"2007","journal-title":"Br J Radiol 80 Spec No"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.58.6.928","article-title":"Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD","volume":"58","author":"N Schuff","year":"2002","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1533317511421780","article-title":"Brain glutamate levels are decreased in Alzheimer&apos;s disease: a magnetic resonance spectroscopy study","volume":"26","author":"N Fayed","year":"2013","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1522-2594(199902)41:2<276::AID-MRM10>3.0.CO;2-8","article-title":"In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging","volume":"41","author":"A Pfefferbaum","year":"1999","journal-title":"Magn Reson Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1176\/appi.ajp.160.11.2003","article-title":"Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer&apos;s disease","volume":"160","author":"KR Krishnan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0047-6374(97)01877-0","article-title":"Proton magnetic resonance spectroscopy can differentiate Alzheimer&apos;s disease from normal aging","volume":"97","author":"L Parnetti","year":"1997","journal-title":"Mech Ageing Dev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","article-title":"Mouse models of Alzheimer&apos;s disease","volume":"88","author":"AM Hall","year":"2011","journal-title":"Brain Res Bull"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1073\/pnas.0505513102","article-title":"Monitoring disease progression in transgenic mouse models of Alzheimer&apos;s disease with proton magnetic resonance spectroscopy","volume":"102","author":"M Marjanska","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2012.07.016","article-title":"Age-related changes in brain metabolites and cognitive function in APP\/PS1 transgenic mice","volume":"235","author":"SQ Chen","year":"2012","journal-title":"Behav Brain Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1159\/000261646","article-title":"Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer&apos;s disease in APP\/PS1 transgenic mice","volume":"28","author":"SQ Chen","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3233\/JAD-2012-112072","article-title":"Proton and phosphorus magnetic resonance spectroscopy of a mouse model of Alzheimer&apos;s disease","volume":"31","author":"V Mlynarik","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000113684","article-title":"Intraneuronal beta-amyloid is a major risk factor\u2013novel evidence from the APP\/PS1KI mouse model","volume":"5","author":"TA Bayer","year":"2008","journal-title":"Neurodegener Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.brainres.2004.05.029","article-title":"Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes","volume":"1017","author":"DR Howlett","year":"2004","journal-title":"Brain Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/nbm.1712","article-title":"Effects of Alzheimer&apos;s disease transgenes on neurochemical expression in the mouse brain determined by (1)H MRS in vitro","volume":"25","author":"DM Forster","year":"2012","journal-title":"NMR Biomed"},{"key":"ref36","first-page":"121","article-title":"Comparison of in vivo1H MRS of human brain tumours with1H HR-MAS spectroscopy of intact biopsy samples in vitro","volume":"8","author":"SJ Barton","year":"1999","journal-title":"Magnetic Resonance Materials in Physics, Biology and Medicine"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Fischer AH, Jacobson KA, Rose J, Zeller R (2008) Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008: pdb prot4986.","DOI":"10.1101\/pdb.prot4986"},{"key":"ref38","first-page":"333","article-title":"Nonamyloid green birefringence following Congo red staining","volume":"104","author":"FL Carson","year":"1980","journal-title":"Arch Pathol Lab Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s004010000248","article-title":"New temperature modification makes the Bielschowsky silver stain reproducible","volume":"101","author":"S Litchfield","year":"2001","journal-title":"Acta Neuropathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1742-7843.2007.00138.x","article-title":"A novel cyclic squamosamide analogue compound FLZ improves memory impairment in artificial senescence mice induced by chronic injection of D-galactose and NaNO2","volume":"101","author":"F Fang","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref41","first-page":"521","article-title":"D-galactose induced brain senescence model and its mechanism","volume":"9","author":"LL Chu J","year":"2003","journal-title":"Chin J Rehabil Theory Practice"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1022417102206","article-title":"Establishment of the mimetic aging effect in mice caused by D-galactose","volume":"4","author":"SC Ho","year":"2003","journal-title":"Biogerontology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbr.2004.07.003","article-title":"Behavioural study of the D-galactose induced aging model in C57BL\/6J mice","volume":"157","author":"H Wei","year":"2005","journal-title":"Behav Brain Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0149-7634(89)80048-X","article-title":"N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain","volume":"13","author":"DL Birken","year":"1989","journal-title":"Neurosci Biobehav Rev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1179\/016164104225017640","article-title":"1H-MRS evaluation of metabolism in Alzheimer&apos;s disease and vascular dementia","volume":"26","author":"RS Jones","year":"2004","journal-title":"Neurol Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000087095","article-title":"A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer&apos;s disease","volume":"20","author":"F Jessen","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neulet.2005.04.035","article-title":"Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer&apos;s disease","volume":"384","author":"N Ackl","year":"2005","journal-title":"Neurosci Lett"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.wnl.0000198256.54809.0e","article-title":"MR spectroscopy of brain white matter in the prediction of dementia","volume":"66","author":"T den Heijer","year":"2006","journal-title":"Neurology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.neurobiolaging.2007.03.002","article-title":"Age related changes in brain metabolites observed by 1H MRS in APP\/PS1 mice","volume":"29","author":"J Oberg","year":"2008","journal-title":"Neurobiol Aging"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/nbm.2875","article-title":"Imaging of glutamate neurotransmitter alterations in Alzheimer&apos;s disease","volume":"26","author":"M Haris","year":"2013","journal-title":"NMR Biomed"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410220110","article-title":"Alzheimer&apos;s disease: glutamate depletion in the hippocampal perforant pathway zone","volume":"22","author":"BT Hyman","year":"1987","journal-title":"Ann Neurol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0925-4927(98)00010-9","article-title":"Metabolic brain mapping in Alzheimer&apos;s disease using proton magnetic resonance spectroscopy","volume":"82","author":"F Lazeyras","year":"1998","journal-title":"Psychiatry Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000111347","article-title":"Multinuclear NMR studies on the energy metabolism of glial and neuronal cells","volume":"15","author":"A Brand","year":"1993","journal-title":"Dev Neurosci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mrm.1910320115","article-title":"Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease","volume":"32","author":"RA Moats","year":"1994","journal-title":"Magn Reson Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/jnr.20984","article-title":"Amyloid beta up-regulates brain-derived neurotrophic factor production from astrocytes: rescue from amyloid beta-related neuritic degeneration","volume":"84","author":"N Kimura","year":"2006","journal-title":"J Neurosci Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/156802606776743075","article-title":"The role of MRI and PET\/SPECT in Alzheimer&apos;s disease","volume":"6","author":"A Coimbra","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2004.02.079","article-title":"Magnetic resonance spectroscopic analysis of Alzheimer&apos;s disease mouse brain that express mutant human APP shows altered neurochemical profile","volume":"1012","author":"A Dedeoglu","year":"2004","journal-title":"Brain Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0088562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T09:47:33Z","timestamp":1597484853000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0088562"}},"subtitle":[],"editor":[{"given":"Cesar V.","family":"Borlongan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,12]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0088562","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,12]]}}}